121 results
Page 5 of 7
8-K
EX-99.1
o9lcffmdl
24 Feb 20
Aeglea BioTherapeutics Reports Fourth-Quarter and Full-Year 2019 Financial Results, Highlights Recent Milestones
7:30am
8-K
EX-99.1
ohuoc92
6 Nov 19
Aeglea BioTherapeutics Reports Third Quarter 2019 Financial Results and Corporate Highlights
8:30am
8-K
EX-99.1
2rfsii eg98a
6 Aug 19
Aeglea BioTherapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights
8:00am
8-K
EX-99.1
0c917 tgj5azln7c
7 May 19
Aeglea BioTherapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights
7:45am
8-K
EX-99.1
l76zfh xo
7 Mar 19
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights
4:05pm
424B5
scybz609e2nbkrt
13 Feb 19
Prospectus supplement for primary offering
4:44pm
8-K
hngu00g60o825vzv4w1
6 Feb 19
Entry into a Material Definitive Agreement
9:40pm
424B5
flrf2 satt
6 Feb 19
Prospectus supplement for primary offering
9:37pm
424B5
5u12evrzd
5 Feb 19
Prospectus supplement for primary offering
4:49pm
8-K
980k0tah bvktg4z
29 Nov 18
Entry into a Material Definitive Agreement
8:00am